COOLUNG&BRAIN

Important results from the project

** Denna text är maskinöversatt ** BrainCool AB advances technologically by updating documentation, conducting successful tests with Intertek, integrating the BrainTemp sensor and initiating an efficient injection molding line. Clinical studies aim to demonstrate the effectiveness of the BrainCool system in stable temperature management. Market expansion includes distribution agreements with ZOLL and major GPOs in the US, EU and Asia. Overall, BrainCool AB strives to be a leader in advanced temperature management, with an emphasis on quality, efficiency and market growth

Expected long term effects

In development, we achieved milestones by updating documentation and successfully testing the system. We delivered 50 units and initiated an injection molding line for efficiency. With an updated 510K, we seamlessly integrated the BrainTemp sensor for improved monitoring. These improvements were applied in clinical studies, which treated 92 patients, demonstrating its effectiveness. As a results, BrainCool AB and ZOLL signed a distribution agreement, which strengthened the market presence. GPO agreements further strengthen our market position in the US

Approach and implementation

** Denna text är maskinöversatt ** Complete third-party test app documents, update ECU-100 with advanced features. New injection molding increases efficiency. BrainCool AB is testing updated ECU-100 with Intertek, producing a significant batch. Get updated 510K for seamless BrainTemp sensor integration. Clinical studies evaluate the effectiveness of the BrainCool system in temperature management and rewarming. Distribution agreements with ZOLL and major GPOs signal successful implementations for expanded market presence.